Liberal Democrat
Disability Association

News

DWP admit to backlog in sickness benefit

At least 35,000 people applying for sickness benefit are waiting longer than 13 weeks, the Department for Work and Pensions (DWP) has admitted. DWP officials are privately blaming the backlog of employment and support allowance claims on French firm Atos, which carries out medical assessments. Atos Healthcare said it had recruited additional staff and extended opening hours in response to the situation. One member of DWP staff described the situation as "in meltdown".

8 Feb 2012
View

Social costs argument to be heard in Supreme Court

The Supreme Court is to hear a case challenging the way councils in England can consider their finances when assessing people for social care. A severely disabled man - known as KM - and four charities will say care should be the same wherever a person lives.

7 Feb 2012
View

Social costs argument to be heard in Supreme Court

The Supreme Court is to hear a case challenging the way councils in England can consider their finances when assessing people for social care. A severely disabled man - known as KM - and four charities will say care should be the same wherever a person lives.

7 Feb 2012
View

Living in a hearing world

For several years cochlear implants have offered some deaf people the chance to have a "sensation of sound". So why would some deaf teenagers choose not to have the implant even if they had the option? The issue of cochlear implants and efforts to "cure" deafness is a very sensitive subject among the 19,600 deaf teenagers in the UK. Indeed, many young deaf people are proud of deaf culture.

6 Feb 2012
View

Diabetes quadruples birth defects risk, say researchers

The risk of birth defects increases four-fold if the pregnant mother has diabetes, researchers say. The Newcastle University study, published in the journal Diabetologia, analysed data from more than 400,000 pregnancies in North East England. The risk of defects such as congenital heart disease and spina bifida were increased.

6 Feb 2012
View

Watchdog NICE says no to eye drug Lucentis for diabetes

A drug that could save the sight of people with diabetes will not be made available on the NHS in England and Wales, an advisory body has concluded. The National Institute for Health and Clinical Excellence (NICE) says ranibizumab, sold under the brand name Lucentis, is too expensive to use in people with diabetic macular oedema.

1 Dec 2011
View

This website uses cookies

Like most websites, this site uses cookies. Some are required to make it work, while others are used for statistical or marketing purposes. If you choose not to allow cookies some features may not be available, such as content from other websites. Please read our Cookie Policy for more information.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.